Products for Research Use Only

VGX-1027

CAT: 0013-GTR19161115-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19161115-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
VGX-1027 (GIT27) is an isoxazole compound that exhibits various immunomodulatory properties; reduce the secretion of IL-1beta, TNF-alpha and IL-10 from purified murine macrophages. (In Vitro) :VGX-1027 (37.5, 75, 150, 300 μM; for 24 h) does not affect the viability of tumor cells, including the three malignant rodent cell lines (mouse fibrosarcoma L929, rat astrocytoma C6, and mouse melanoma B16) and the four human cell lines (adenocarcinoma HeLa, breast carcinoma BT20, colon carcinoma LS174, and glioblastoma U251) . (In Vivo) :VGX-1027 (10, 20 mg/kg of i.p. for 12 day or 100 mg/kg of p.o. for 11 day) successfully counteractes the development of destructive insulitis and hyperglycemia.VGX-1027 (25 mg/kg; ip; single dose) counteracts the uveitis-inducing effect of LPS in eight-week-old male Lewis rats (180-220 g) .
CAS Number
6501-72-0
Product Name Alternative
VGX-1027
Purity
>98% (HPLC)
Solubility
Ethanol: 41 mg/mL (199.79 mM) ; DMSO: 41 mg/mL (199.79 mM)
Smiles
O=C (O) CC1CC (C2=CC=CC=C2) =NO1
Molecular Formula
C11H11NO3
Molecular Weight
205.21
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2- (3-phenyl-4,5-dihydroisoxazol-5-yl) acetic acid